Negative prostatic biopsies in patients with a high risk of prostate cancer: Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study

European Urology

Volumn 47, Issue 5, 2005, Pages 582-586

  Amsellem Ouazana, Delphine ^a   Younes, Patrick ^a   Conquy, Sophie ^a   Peyromaure, Mickaël ^a   Flam, Thierry ^a   Debré, Bernard ^a   Zerbib, Marc ^a  

^a Service d'Urologie ^*  (France)

Author keywords

Detection; MRI; MRSI; Prostate cancer

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEMOCONCENTRATION; HIGH RISK POPULATION; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY ANALYSIS; SIGNAL DETECTION; STANDARD; STATISTICAL SIGNIFICANCE;

EID: 17144380055     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.01.015     Document Type: Article

References (18)

1. B. Zackrisson, G. Aus, S. Bergdahl, H. Lilja, P. Lodding, and C.G. Pihl The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable J Urol 171 2004 1500 1503
2. J.C. Rabets, J.S. Jones, A. Patel, and C.D. Zippe Prostate cancer detection with office based saturation biopsy in a repeat biopsy population J Urol 172 2004 94 97
3. M. Perrotti, K.R. Han, R.E. Epstein, E.C. Kennedy, F. Rabbani, and K. Badani Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study J Urol 162 1999 1314 1317
4. A.E. Wefer, H. Hricak, D.B. Vigneron, F.V. Coakley, Y. Lu, and J. Wefer Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 2000 400 404
5. J. Nakashima, A. Tanimoto, Y. Imai, M. Mukai, Y. Horiguchi, and K. Nakagawa Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer Urology 64 2004 101 105
6. L. Wang, M. Mullerad, H.N. Chen, S.C. Eberhardt, M.W. Kattan, and P.T. Scardino Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension Radiology 232 2004 133 139
7. 3) spatial resolution Radiology 198 1996 795 805
8. M. Hasumi, K. Suzuki, N. Oya, K. Ito, K. Kurokawa, and Y. Fukabori MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer Anticancer Res 22 2002 1205 1208
9. J. Scheidler, H. Hricak, D.B. Vigneron, K.K. Yu, D.L. Sokolov, and L.R. Huang Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study Radiology 213 1999 473 480
10. S. Ikonen, P. Karkkainen, L. Kivisaari, J.O. Salo, K. Taari, and T. Vehmas Magnetic resonance imaging of clinically localized prostatic cancer J Urol 159 1998 915 919
11. F. Cornud, T. Flam, L. Chauveinc, K. Hamida, Y. Chretien, and A. Vieillefond Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results Radiology 224 2002 203 210
12. D. Beyersdorff, M. Taupitz, B. Winkelmann, T. Fischer, S. Lenk, and S.A. Loening Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging Radiology 224 2002 701 706
13. J.C. Vilanova, J. Comet, A. Capdevila, J. Barcelo, J.L. Dolz, and M. Huguet The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients Eur Radiol 11 2001 229 235
14. L. Salomon, M. Colombel, J.J. Patard, M.A. Lefrere-Belda, J. Bellot, and D. Chopin Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping Eur Urol 35 1999 289 293
15. C.H. Chon, F.C. Lai, J.E. McNeal, and J.C. Presti Jr. Use of extended systematic sampling in patients with a prior negative prostate needle biopsy J Urol 167 2002 2457 2460
16. J.C. Presti Jr., G.J. O'Dowd, M.C. Miller, R. Mattu, and R.W. Veltri Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study J Urol 169 2003 125 129
17. J.S. Yuen, C.H. Thng, P.H. Tan, L.W. Khin, S.J. Phee, and D. Xiao Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy J Urol 171 2004 1482 1486
18. J.J. Futterer, T.W. Scheenen, H.J. Huisman, D.W. Klomp, F.A. van Dorsten, and C.A. Hulsbergen-van de Kaa Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate Invest Radiol 39 2004 671 680